Clinical trial
Canadian Aesthetic Experience With Sculptra Therapy
NCT00447551 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00447551 |
|---|---|
| Title | Canadian Aesthetic Experience With Sculptra Therapy |
| Official title | Canadian Study of the Use of Injectable POLY-L-LACTIC Acid (Sculptra Therapy) in Aesthetic Medicine |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Skin Aging |
| Intervention type | Drug |
| Interventions | Poly-L-Lactic Acid |
| Enrollment | 76 |
| Start date | Jan 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Mar 14, 2007 |
| Last update posted | Nov 19, 2019 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: